Iridex Corporation launched its next-generation platform Iridex 532 and Iridex 577 lasers that leverage continuous-wave and patented MicroPulse Technology and an intuitive touchscreen interface for treating glaucoma and retinal disorders.

“I was very pleased with the compact design and intuitive user interface,” noted Sam Mansour, MD, medical director of the Virginia Retina Center, in a company news release. “Its treatment-session recordings enhance therapeutic tracking from subsequent laser sessions, and the rapid maneuverability between console menus will undoubtedly improve patient flow. Having used Iridex laser systems for 30 years, I can attest to the highly dependable quality of their products.”

Product highlights include comprehensive treatment reports, configurable preset filters, enhanced user experience, and MicroPulse laser delivery modality. “The launch ... stands as a testament to our 35-year heritage of providing advanced laser solutions to ophthalmologists worldwide,” said President and CEO of Iridex David Bruce.